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BACKGROUND: Personal care products (PCPs) are exposure sources to phthalates and parabens; however, their contribution to men’s exposure is
understudied.
OBJECTIVES:We examined the association between PCP use and urinary concentrations of phthalate metabolites and parabens in men.
METHODS: In a prospective cohort, at multiple study visits, men self-reported their use of 14 PCPs and provided a urine sample (2004–2015, Boston,
MA). We measured urinary concentrations of 9 phthalate metabolites and methylparaben, propylparaben, and butylparaben. We estimated the
covariate-adjusted percent change in urinary concentrations associated with PCP use using linear mixed and Tobit mixed regressions. We also esti-
mated weights for each PCP in a weighted binary score regression and modeled the resulting composite weighted PCP use.
RESULTS: Four hundred men contributed 1,037 urine samples (mean of 3/man). The largest percent increase in monoethyl phthalate (MEP) was asso-
ciated with use of cologne/perfume (83%, p-value<0:01) and deodorant (74%, p-value <0:01). In contrast, the largest percent increase for parabens
was associated with the use of suntan/sunblock lotion (66–156%) and hand/body lotion (79–147%). Increases in MEP and parabens were generally
greater with PCP use within 6 h of urine collection. A subset of 10 PCPs that were used within 6 h of urine collection contributed to at least 70% of
the weighted score and predicted a 254–1,333% increase in MEP and parabens concentrations. Associations between PCP use and concentrations of
the other phthalate metabolites were not statistically signiﬁcant.
CONCLUSIONS:We identiﬁed 10 PCPs of relevance and demonstrated that their use within 6 h of urine collection strongly predicted MEP and paraben
urinary concentrations. https://doi.org/10.1289/EHP1374
Introduction
There is ubiquitous general population exposure to ortho-
phthalates (hereafter referred to as phthalates) and several para-
bens (CDC 2017). Phthalates are a family of chemicals com-
monly used as plasticizers in polyvinyl chloride plastics and in
consumer products, including personal care products (PCPs),
medications, and food processing and packaging materials (CDC
2017). Diethyl phthalate (DEP) is the most commonly used
phthalate in PCPs (FDA 2014b). Parabens are a family of chem-
icals with antimicrobial preservative properties that are also
widely used in PCPs, pharmaceuticals, food, and beverages to
increase the shelf life of the product (Dodson et al. 2012; FDA
2014a; Guo and Kannan 2013; Moos et al. 2014). Methylparaben,
propylparaben, and butylparaben are most commonly used in
PCPs (Braun et al. 2014; Dodson et al. 2012; Ferguson et al.
2017).
In multiple urine samples collected from two men and three
women, Koch et al. (2013) found that concentrations of the
metabolites of low molecular weight phthalates such as DEP, di-
n-butyl phthalate (DnBP), and di-isobutyl phthalate (DiBP) had a
cyclical pattern of rise and decline suggestive of ongoing
repeated nonfood exposures. Koch et al. (2013) also found that
monoethyl phthalate (MEP; a metabolite of DEP), concentrations
increased following showers, which suggested PCPs as a major
source of DEP exposure. Koch et al. (2014) also found that uri-
nary concentrations of the parabens were lower when the partici-
pants were given products without parabens.
Exposure to phthalates and parabens from PCP use occurs
through direct dermal application (Janjua et al. 2008; Seo et al.
2016), inhalation, oral ingestion, or even transdermal exposure
from air (Weschler et al. 2015). Phthalates and parabens have
short biological half-lives (6–24 h) (Janjua et al. 2008; Koch
et al. 2012; Moos et al. 2016), and urinary concentrations of
phthalate metabolites and parabens are the preferred exposure
biomarkers (Calafat et al. 2015; CDC 2017).
Certain phthalates and parabens are endocrine disruptors and
have been linked to adverse health outcomes (Boberg et al. 2010;
Hannas et al. 2012; Howdeshell et al. 2016; Lioy et al. 2015;
Orton et al. 2014; Zoeller et al. 2014). Identifying the most im-
portant sources of phthalate and paraben exposure is of para-
mount importance given the widespread use and potential health
eﬀects of these chemicals. Prior epidemiological studies on the
contribution of PCP use to exposure to phthalates and parabens
focused primarily on women and children (Braun et al. 2014;
Buckley et al. 2012; Ferguson et al. 2017; Harley et al. 2016; Just
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et al. 2010; Martina et al. 2012; Philippat et al. 2015; Romero-
Franco et al. 2011; Sathyanarayana et al. 2008). However, there
have been limited studies in men (Duty et al. 2005; Ferguson
et al. 2017). Given both diﬀerences in type and frequency of PCP
use across both sexes, better understanding of the speciﬁc PCPs
contributing to urinary phthalate metabolite and paraben concen-
trations in men is necessary.
Given this gap in knowledge on the contribution of PCP use
to exposure to phthalates and parabens in men, we explored the
association between self-reported use of 14 PCPs and urinary
concentrations of 9 urinary phthalate metabolites and 3 parabens
in men recruited as part of a prospective cohort study. Because of
the known use of DEP, DiBP, and parabens in PCPs (Dodson
et al. 2012; Wittassek et al. 2011), we focused on MEP, mono-
isobutyl phthalate (MiBP; a metabolite of DiBP), methylparaben,
propylparaben, and butylparaben. We considered including mono-
n-butyl phthalate (MnBP; a metabolite of DnBP), but because
DnBP is infrequently used in PCPs (FDA 2014b), it was not a
focus of our analysis.
Methods
Participants
The Environment And Reproductive Health (EARTH) study
(2004–present), a prospective cohort, enrolled couples seeking
fertility treatment at the Massachusetts General Hospital (MGH)
Fertility Center to identify determinants of fertility (Braun et al.
2014; Dodge et al. 2015). Among male partners who were 18–55
y of age, approximately 50% agreed to participate. Male partici-
pants were followed from study enrollment until their partner had
a live birth or the couple discontinued treatment at MGH.
Approximately 30% of EARTH men had a primary diagnosis of
male factor infertility (Dodge et al. 2015). In the current analysis,
men were eligible if they provided at least one urine sample and
completed the PCP questionnaire [see “Product Use Questionnaire
in the Environment And Reproductive Health (EARTH) Study” in
the Supplemental Material] between December 2004 and June
2015. All men provided informed consent. The EARTH study was
approved by institutional review boards at MGH, the Harvard T.
H. Chan School of Public Health, and the Centers for Disease
Control and Prevention (CDC).
Personal Care Product (PCP) Use Questionnaire
Upon enrollment, men completed questionnaires that collected
information on demographics, lifestyle, and health information,
and a research nurse measured their height and weight. At recruit-
ment and at each subsequent visit, men completed a questionnaire
on PCP use within the past 24-h and at what time they last used
each PCP prior to the collection of each urine sample. There
were questions for the use of 16 PCPs, but in the analysis we
excluded toothpaste (used in 98% of men) and nail polish (<1%
use). Therefore, we included deodorants, shampoo, conditioner/
crème rinse, hairspray/hair gel, combined other hair care products
(including mousse, hair bleach, relaxer, perm, and straightener),
shaving cream, aftershave, cologne/perfume, mouthwash, bar
soap, liquid soap/body wash, hand sanitizer, hand/body lotion,
and suntan/sunblock lotion.
Based on our previous publication that showed higher urinary
concentrations of MEP following PCP use in men from the same
fertility clinic population (Duty et al. 2005) and another study
that showed higher urine concentrations following dermal expo-
sure through lotion application (Janjua et al. 2007), we a priori
decided to explore both a 6-h and a 24-h time window for PCP
use before the urine collection. Furthermore, in women from the
same fertility clinic population, we reported higher urinary bio-
marker concentrations when the product was used within 6 h
prior to urine sample collection (Braun et al. 2014).
Urinary Measurements of Phthalate Metabolite and
Paraben Concentrations
At each visit, men collected urine in a sterile polypropylene cup
using standard procedures. Study staﬀ recorded the time of col-
lection and measured speciﬁc gravity (SG) using a handheld re-
fractometer (National Instrument Co. Inc.). Urine samples were
divided into aliquots, frozen, and stored at −80C before ship-
ment on dry ice to the CDC. Brieﬂy, the analytical technique for
quantiﬁcation of the urinary biomarkers involved enzymatic
deconjugation of the urinary metabolites, followed by solid-
phase extraction, separation by high performance liquid chro-
matography, and detection by isotope-dilution tandem mass
spectrometry.
As previously described (Silva et al. 2007; Zhou et al. 2014),
the CDC used solid-phase extraction–high performance liquid
chromatography–isotope-dilution tandem mass spectrometry to
quantify total (free plus conjugated) urinary concentrations (lg=L)
of three parabens (methylparaben, propylparaben, and butylpara-
ben) and nine phthalate metabolites: MEP, MnBP, MiBP, mono-
benzyl phthalate [MBzP; a metabolite of butylbenzyl phthalate
(BBzP)], mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-
oxohexyl) phthalate (MEOHP), mono(2-ethyl-5-hydroxyhexyl)
phthalate (MEHHP), mono(2-ethyl-5-carboxypentyl) phthalate
(MECPP) [MEHP, MEOHP, MEHHP, and MECPP are all
metabolites of di(2-ethylhexyl) phthalate (DEHP)], and mono
(3-carboxypropyl) phthalate [MCPP; a nonspeciﬁc metabolite
of DnBP, di-n-octyl phthalate (DOP), and other high-molecular–
weight phthalates]. We also calculated the molar sum of DEHP
metabolites (
P
DEHP) (Braun et al. 2014). The limits of detection
(LOD) ranged from 0.10 (propylparaben, butylparaben) to 1:20 lg=L
(MEHP). Concentrations below the LOD were replaced by the
LOD divided by the square root of 2 for all biomarkers detected
in at least 90% of the samples (Hornung and Reed 1990; Lubin
et al. 2004).
Statistical Analysis
We calculated descriptive statistics for participants’ baseline
characteristics (such as age, race, education, BMI, and smoking);
time-varying characteristics (such as time of the day, season, and
calendar year of the sample collection); and personal care product
use patterns. Because of the relatively short half-lives of phtha-
lates and parabens (Janjua et al. 2008; Koch et al. 2012; Moos
et al. 2016) and ﬁndings of previous publications, we deﬁned
PCP use as use within the last 24 and 6 h before urine collection.
We used two approaches for assessing men’s use of PCPs. The
ﬁrst approach (single-PCP analyses) deﬁned use of each PCP as a
binary variable (yes/no use within the 24 h preceding urine col-
lection). Because multiple PCPs contributed to the overall body
burden of phthalates and parabens, in our second approach
(multi-PCP analyses) we used a composite weighted PCP score
(continuous variable) as explained below.
The nine urinary concentrations of phthalate metabolites,P
DEHP, and three parabens were modeled as continuous vari-
ables. We examined distributions for the urinary concentrations,
and because of observed skewness, we used a natural log-
transformation to satisfy regression model assumptions. We
examined the Spearman correlations among the concentrations
of phthalate metabolites and parabens.
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Covariate Adjustment
Selection of covariates was based a priori on directed acyclic
graphs and previous literature (Braun et al. 2014; Duty et al.
2005; Smith et al. 2012). The ﬁnal model included urine speciﬁc
gravity (continuous) (O’Brien et al. 2016) to account for urine
dilution, race (Caucasian or not), age (continuous), body mass
index (BMI) (continuous), calendar year [continuous, because it
has been shown that urinary concentrations of several phthalate
metabolites have changed over time in the United States (Zota
et al. 2014)], three categories for time of urine sample collection
[early morning (between 0500 and 0900 hours), late morning
(between 0901 and 1200 hours), or afternoon (after 1201 hours)],
current smoking (yes/no), and warm season (April through
September) (yes/no) to account for seasonality in Boston with
higher use of certain products, speciﬁcally sunscreen, in the
summer.
Multiple Imputations of the Data
Some men had incomplete PCP-use data across their repeated
visits and two men were missing BMI. The missingness for each
PCP question ranged from 5 (for shampoo) to 339 (for hand/body
lotion). Distributions of the urinary concentrations of phthalate
metabolites and parabens were not statistically diﬀerent when
comparing the complete and incomplete PCP-use data, suggest-
ing that missingness was not related to our outcomes and would
not likely impact our ﬁndings. We investigated missingness pat-
terns for PCPs use and the concordance of PCP use within the
same man over repeated visits. We used multiple imputation to
account for the missing data, using multiple imputation by
chained equations (MICE) (Sterne et al. 2009; White et al. 2011)
for imputing missing PCP-use data and covariates (two men
missing BMI). For any given PCP at any time point, the predic-
tors were the same PCP used at other time points, urine speciﬁc
gravity (O’Brien et al. 2016), race, age, BMI, calendar year, time
of sample collection, current smoking, and season. We generated
10 imputed datasets for each analysis and used these imputed
datasets in the main analysis using both of the analytical
approaches described below using proc mianalyze in SAS (ver-
sion 9.4; SAS Institute Inc., Cary, NC).
Regression Models Analysis
Single-PCP analyses. We ﬁrst regressed each biomarker (andP
DEHP) concentration on a single-PCP and covariates in sepa-
rate linear mixed eﬀects models (LMEM) with a random inter-
cept to account for within-person correlation among multiple
longitudinal measures of a given biomarker. Because MEHP and
butylparaben had >10% nondetectable concentrations, we used
mixed Tobit regression (Tobin 1958) models with random inter-
cepts for left-censored data (Lubin et al. 2004). For MEHP and
butylparaben, we took into account LODs from diﬀerent analytic
batches over the study period by specifying a unique LOD for
each sample collection within the Tobit regression. In addition,
we regressed all biomarkers on a continuous variable for total
sum (0 to 14) of the PCPs used by each man at each visit.
We created heatmaps for better visualization of the estimated
percent change (% change) in the urinary concentrations associ-
ated with each PCP use based on LMEM (or Tobit models for
MEHP and butylparaben). We adjusted for the covariates men-
tioned above in all models. We considered two-sided alpha
<0:05 as statistically signiﬁcant and indicated signiﬁcance as
asterisks in heatmaps.
We further explored the association between the PCP use within
6 h before urine collection (yes/no) for ﬁve of the urinary concentra-
tions that were most likely to have PCP use as sources of their parent
compound, that is, MEP (for DEP), MiBP (for DiBP), methylpara-
ben, propylparaben, and butylparaben (Buckley et al. 2012;
Dodson et al. 2012; Philippat et al. 2015; Wittassek et al. 2011).
Multi-PCP analyses. To analyze the simultaneous impact of
the 14 PCPs on a given biomarker concentration, we modiﬁed the
weighted quantile score (WQS) regression model previously used
for quantifying the impact of environmental mixtures on an out-
come (Carrico 2013; Carrico et al. 2015; Christensen et al. 2013;
Gennings et al. 2010, 2013). Given the high dimensionality and
inherent correlations among the use of diﬀerent PCPs as well as
correlations among phthalate metabolites and parabens urinary
concentrations, traditional regression is unsuitable (Carrico
2013). In addition, in previous simulation analyses, the WQS
showed improvements over ordinary regression and LASSO
(Carrico 2013). The WQS approach assumes that a given bio-
marker urinary concentration is associated with a PCP-use compos-
ite score, where this score encompasses a linear combination of
PCP (0/1) use indicators. For a given urinary concentration, the
approach estimates simultaneously PCP weights and an eﬀect esti-
mate for the resulting composite score within a regression model
framework. Within each imputed data set, we used bootstrapping to
empirically estimate the weights, and the data set was split (50/50)
into a training set and a test set to provide valid inferences (e.g.,
p-values) for the estimated slope of the composite score. For bio-
markers with a small percent of nondetectable concentrations (up to
10% below LOD), we constructed a weighted binary score (WBS)
within the linear regression framework. For biomarkers with a mod-
erate percent of concentrations below the LOD (>10% and <70%
below LOD), we performed WBS estimation within the Tobit
regression model.
Table 1. Demographics for 400 men who contributed 1,037 urine samples in
the Environment And Reproductive Health (EARTH) study.
Baseline characteristics N (%) or mean±SD [range]
Age (years) 36:5± 5:50 [23.9, 66.6]
Race
Caucasian 343 (86)
Black/African American 13 (3)
Asian 29 (7)
Other 15 (4)
BMI (kg=m2)a 27:5± 4:45 [18.6, 50.0]
BMI categories
Underweight: <18:5 2 (1)
Normal weight: 18:5≤BMI<25 114 (28)
Overweight: 25≤BMI<30 192 (48)
Obese: BMI≥30 92 (23)
Education categoriesa
Less than college graduate 50 (16)
College graduate 109 (34)
Graduate degree 158 (50)
Current smoking status
Yes 26 (7)
No 374 (93)
Time-varying characteristics for urine sample
collection
n (%)
Warm season (April–September) 477 (46)
Calendar year
2004–2009 522 (50)
2010–2015 515 (50)
Time of the day
Early morning: >0500 and ≤0900 hours 385 (37)
Late morning until noon: >0900 and
≤1200 hours
432 (42)
Afternoon: >1200 hours 220 (21)
Note: BMI, body mass index; N, men’s number; n, urine samples’ number; SD, standard
deviation. N (number of men) or n (number of urine samples) (%) were used for categor-
ical/binary variables and mean±SD [range] for continuous variables.
aTwo men missing information on BMI and 83 missing education.
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We present results as weighted % change in urinary concen-
trations of MEP, MiBP and the three parabens associated with an
increase in the weighted score of the 14 PCPs, as well as the cor-
responding weight for each PCP (sum to 100%). Similarly, we
a priori chose to present the number of PCPs (could be diﬀerent
depending on the chemical) that summed to at least 70% of the
weighted score. The 70% of the weighted score should provide a
reasonable prediction of exposure as compared with 100% of the
weighted score, and may therefore be applicable for future
research on exposure from PCPs. We repeated these analyses for
PCPs use with 6 h of urine collection for the ﬁve urinary concen-
trations of higher interest.
Sensitivity analyses. Given the low detection frequency for
butylparaben (31%), we performed a secondary analysis using
generalized estimating equations (GEE) with logit link after
we dichotomized butylparaben urinary concentrations into detect-
able versus nondetectable concentrations (Dodge et al. 2015).
We adjusted for the same covariates as in the primary analyses.
We report adjusted odds ratios of detection associated with PCP
use along with p-values). We repeated all analyses using only the
complete case analyses (with no imputation). Analyses were also
repeated after imputing the missing PCP data as “0,” assuming
missing was “no use.”
We conducted statistical analyses using SAS version 9.4
(SAS Institute Inc., Cary, NC) and used the (heatmap.2) R pack-
age for heatmap generation (version 3.1.2; R Development Core
Team).
Results
In the ﬁnal analysis, 400 men contributed 1,037 urine samples
with an average of 3 samples per man (up to 12 samples); 29%
of the men provided 1 urine sample, 31% provided 2, and 40%
provided at least 3. The median time between any two consecu-
tive urine collections per man was 77 d (interquartile range: 34–
126 d).
The men were mostly Caucasian (86%), nonsmokers (93%),
and had a median age of 36 y, median BMI of 27 kg=m2, and a
college or graduate education (84%) at the time of enrollment.
Urine collection time ranged from 0600 to 1800 hours with 42%
Table 2. Self-reported use of 14 personal care products (PCPs) within 24 and 6 h of collection of urine sample among 400 men in the Environment And
Reproductive Health (EARTH) study.
Personal care products (PCPs) n (answered yes/no)
N (answered yes/no and
reported time since last used)
n (%) answered yes
within 24 h
n (%) answered yes
within 6 h
% concordanta
over time
Deodorant 1,029 1,023 879 (85) 723 (71) 82
Shampoo 1,032 1,024 832 (81) 584 (57) 74
Conditioner/crème rinse 946 941 220 (23) 149 (16) 76
Hairspray/hair gel 952 948 291 (31) 222 (23) 83
Other hair care productsb 914 910 66 (7) 46 (5) 90
Shaving cream 993 993 390 (39) 263 (26) 62
Aftershave 800 799 79 (10) 53 (7) 87
Cologne/perfume 955 952 202 (21) 145 (15) 79
Mouthwash 975 969 325 (33) 199 (21) 72
Bar soap 1,003 1,001 755 (75) 567 (57) 81
Liquid soap/body wash 1,016 990 732 (72) 508 (51) 55
Hand sanitizer 726 714 219 (30) 128 (18) 47
Hand/body lotion 698 695 162 (23) 102 (15) 81
Suntan/sunblock lotion 863 862 25 (3) 12 (1) 93
Note: n, number of visits/urine samples; PCPs, personal care products.
aConcordant: same answer for product use within 24 h over different visits for the same man, only includes observations for men who completed at least two visits.
bCombined other hair care products included mousse, hair bleach, relaxer, perm, and straightener.
Table 3. Distributions of urinary concentrations of phthalate metabolites and parabens measured in 400 men (n=1,037 urine samples)a in the Environment
And Reproductive Health (EARTH) study.
Urinary concentrationsb (lg=Lc) % (>LODd) GM
10th
perc
25th
perc
50th
perc
75th
perc
90th
perc
GM
(NHANES)e
2005–2006
GM
(NHANES)e
2009–2010
GM
(NHANES)e
2011–2012
Monoethyl phthalate (MEP) 100 48.8 6.86 16.6 42.0 145 458 107 61.0 38.1
Mono-n-butyl phthalate (MnBP) 98 10.6 2.00 4.90 12.4 24.7 43.6 19.8 14.5 8.14
Mono-isobutyl phthalate (MiBP) 97 6.44 1.20 3.20 7.40 14.9 27.2 5.65 7.80 6.54
Monobenzyl phthalate (MBzP) 95 3.25 0.50 1.37 3.60 8.10 16.2 9.47 6.93 4.80
Mono(2-ethylhexyl) phthalate (MEHP) 78 3.03 <LOD 0.85 2.80 7.80 24.9 3.40 1.83 1.51
Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) 99 10.3 1.40 3.80 9.80 24.8 84.1 18.3 9.14 5.50
Mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) 100 17.3 2.40 6.00 16.2 45.3 148 29.6 15.2 8.71
Mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) 100 27.7 4.30 10.5 26.1 65.5 209 43.6 23.4 14.3P
DEHP (di(2-ethylhexyl) phthalate) metabolites
(lmol=Lf)
— 0.20 0.03 0.07 0.19 0.49 1.57 — — —
Mono(3-carboxypropyl) phthalate (MCPP) 97 3.85 0.60 1.60 3.70 9.70 23.2 2.32 3.37 3.52
Methylparaben 99 28.0 4.70 9.40 23.2 80.4 226 29.8 31.7 23.2
Propylparaben 90 2.86 0.14 0.60 2.30 12.1 58.6 2.96 2.77 2.44
Butylparaben 31 0.26 <LOD <LOD <LOD 0.30 2.20 <LOD <LOD <LOD
Note: GM, geometric mean; LOD, limit of detection; NHANES, National Health and Nutrition Examination Survey; perc, percentile; SD, standard deviation.
aPhthalate metabolites were measured in 1,037 urine samples from 400 men and parabens in 965 samples from 383 men.
bUrinary concentrations were ordered according to the molecular weights within phthalates and within parabens.
cConcentrations in lg=L (except for
P
DEHP) were not corrected for urine dilution; concentrations <LOD were replaced by the LOD divided by the square root of 2.
dLOD range (in lg=L) for MnBP: 0.4, 0.6; MiBP: 0.2, 0.3; MBzP: 0.2, 0.3; MEHP: 0.5, 1.2; MEOHP: 0.2, 0.7; MEHHP: 0.2, 0.7; MCPP: 0.18, 0.2; M_pb: 1; B_pb: 0.1, 0.2; B_pb:
0.1, 0.2.
eConcentrations from NHANES (2005–2006), (2009–2010), and (2011–2012) because our data encompassed the years 2004–2015.
fPDEHP metabolites ðlmol=LÞ= lmol=L sum of MEHP+MEOHP+MEHHP+MECP.
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collected between 0900 and 1200 hours, and 46% of the samples
collected in the warm season (Table 1).
Deodorants and shampoos were the most frequently (>80%)
used PCPs. Suntan/sunblock lotion and other hair care products
were the least frequently (<10%) used PCPs (Table 2). The con-
cordance between speciﬁc PCP use at diﬀerent study visits within
the same men was relatively high, ranging from 47% for hand
sanitizer to 93% for suntan/sunblock lotion.
The percentage of samples (2004–2015) with detectable
urinary concentrations of phthalates and parabens biomarkers
ranged from 90% to 100% except for MEHP (78%) and butyl-
paraben (31%) (Table 3). The men’s median urinary MEP and
paraben concentrations were substantially lower than the medians
for women from the same cohort (Braun et al. 2014) but compara-
ble to male urinary concentrations from the National Health and
Nutrition Examination Survey (NHANES) (CDC 2017) (Table 3).
Spearman correlations were generally weak between phthalate
metabolites and parabens (range: 0.09–0.32), weak to strong
among diﬀerent phthalate metabolites (range: 0.22–>0:99) with
the strongest correlation occurring between metabolites from the
same parent compound (e.g., DEHP), and moderate to strong
among diﬀerent parabens (range: 0.41–0.80) (see Figure S1).
Strong correlations indicate similar sources and weak correla-
tions indicate diﬀerent sources of exposure. These correlations
are in accordance with results shown in Figure 1.
The adjusted % changes in urinary concentrations (by the
single-PCP approach) were highest for MEP (e.g., 83% increase
with cologne/perfume use and 74% increase with deodorant use)
(Figure 1). Hairspray/hair gel, aftershave, mouthwash, shaving
cream, and other hair care products predicted MEP concentra-
tions (18–31% increase). For the three parabens, the strongest
predictors were use of suntan/sunblock lotion (66–156% increase)
and of hand/body lotion (79–147% increase). Hairspray/hair gel,
shaving cream, aftershave, mouthwash, and deodorant were
Figure 1. Heatmap for adjusted % change in urinary phthalate metabolite and parabens concentrations associated with self-reported use of personal care prod-
ucts (PCPs) within 24 h of urine sample collection among 400 men who contributed 1,037 urine samples in the Environment And Reproductive Health
(EARTH) study. Abbreviations: DEHP means,
P
DEHP metabolites ðlmol=LÞ= sum of lmol=L of MEHP+MEOHP+MEHHP+MECPP; total products:
the crude sum of PCP used within 24 h. Multiple imputation of the missing was based on concordance of product use within persons. For any given PCP at
any time point, the imputation model included PCP use at other time points, urine speciﬁc gravity (continuous), race (Caucasian or not), age (continuous), BMI
(continuous), calendar year (continuous), time of sample collection [early morning (>0500 and ≤0900 hours), late morning (>0900 hours and ≤1200 hours), or
afternoon (>1200 hours)], current smoking (yes/no), and warm season (April–September) (yes/no). Analysis adjusted for urine speciﬁc gravity (continuous),
race (Caucasian or not), age (continuous), BMI (continuous), calendar year (continuous), time of sample collection [early morning (>0500 and ≤0900 hours),
late morning (>0900 hours and ≤1200 hours), or afternoon (>1200 hours)], current smoking (yes/no), warm season (April–September) (yes/no), and the prod-
uct use within 24 h (yes/no). The last column for the total products represents % changes associated with each additional type of PCP used, regardless of which
PCP. Urinary concentrations were ordered according to the molecular weights within phthalates and within parabens. Combined other hair care products
included mousse, hair bleach, relaxer, perm, and straightener. Analysis was based on 10 imputed data using the chained equations method. *p-value<0:05.
**p-value<0:01.
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Figure 2. Adjusted % change in urinary concentrations of parabens and phthalate metabolites associated with 14 personal care products used within 24 and 6 h
of urine collection: (A) monoethyl phthalate (MEP) urinary concentration; (B) mono-isobutyl phthalate (MiBP) urinary concentration; (C) butylparaben urinary
concentration; (D) methylparaben urinary concentration; and (E) propylparaben urinary concentration. Multiple imputation of the missing was based on con-
cordance of product use within persons. For any given PCP at any time point, the imputation model included PCP use at other time points, urine speciﬁc grav-
ity (continuous), race (Caucasian or not), age (continuous), BMI (continuous), calendar year (continuous), time of sample collection [early morning (>0500
legend/caption continues on the next page
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moderate predictors for parabens. Liquid soap/body wash use
was a strong predictor only for butylparaben (86%). Apart from
hand sanitizer and bar soap, the rest of the PCPs were moderate
to weak predictors of the three parabens. Each additional type of
PCP used, regardless of which PCP, was associated with a 12%
increase in MEP and a 14–29% increase in parabens urinary concen-
trations. Although shampoo use was signiﬁcantly associated with a
33% increase in the urinary concentrations of MEHP, it was not sig-
niﬁcantly associated with the other DEHP metabolites. The associa-
tions between PCP use and urinary concentrations of other
phthalate metabolites were weak to null, and sometimes even nega-
tive, but none were statistically signiﬁcant. The percent increase in
the urinary concentrations associated with PCP use within 6 h of
urine collection was generally larger and more statistically signiﬁ-
cant than for use within 24 h (Figure 2).
In the multi-PCP approach, we presented the diﬀerent weights
for each PCP depending on the association with each biomarker
so that the 14 PCPs sum to 100%. When regressing these com-
posite scores, we found that a 1-unit increase in the weighted
score of the use of all 14 PCPs was associated with an increase in
MEP and paraben urinary concentrations ranging from 700% to
1,398% for samples collected within 24 h of PCP use (Figure 3A;
see also Table S1). When we limited PCP use to the last 6 h, a
1-unit increase in the weighted score was associated with a 458–
3,626% increase in urinary concentrations of MEP and the para-
bens (Figure 3B; see also Table S1).
We also present in Figure 3C, 3D the adjusted weighted %
change in the urinary concentrations associated with the PCPs mak-
ing up at least 70% of the weighted score as contributed by the high-
est weighted PCPs for each chemical use within 24 and 6 h of urine
collection, along with the weights for each PCP (sum to at least
70%). The adjusted weighted % change in the urinary concentrations
of MEP and the three parabens was associated with six or fewer
PCPs (depending on the biomarker) and ranged from a 111% to a
591% increase within 24 h of urine collection and up to a 1,333%
increase within 6 h of urine collection. MiBP urinary concentration
was not strongly predicted by the weighted PCP score.
For MEP and the three parabens individually, seven or fewer
PCPs used within 24 or 6 h explained at least 70% of the
weighted PCP score. The adjusted weighted % changes within
6 h were generally higher than within 24 h of urine collection.
Overall, use of 10 PCPs within 6 h prior to collection explained
at least 70% of the weighted score. These included cologne/
perfume, deodorant, suntan/sunblock lotion, hand/body lotion,
aftershave, other hair care products, mouthwash, conditioner/
crème rinse, hairspray/hair gel, and liquid soap/body wash,
which explained at least a 254% and up to a 1,333% increase
in MEP and the three parabens urinary concentrations (Figure
3C, 3D).
Secondary analyses performed by modeling butylparaben as a
dichotomous outcome (detected vs. nondetected) provided odds
ratios that were consistent with the direction of the % changes
from Tobit regression (see Table S2). Sensitivity analyses using
the complete case analysis (with no imputation) and after imput-
ing the missing PCP use as no use gave consistent results with
the main analysis (see Figures S2–S5 and Tables S3–S6).
Discussion
We found that self-reported PCP use among men was associated
with higher urinary concentrations of MEP and three parabens
(methyparaben, propylparaben, and butylparaben). As expected
and consistent with a prior study of women in the same cohort
(Braun et al. 2014), due to the short half-lives of phthalates and
parabens (Janjua et al. 2008; Koch et al. 2012; Moos et al. 2016)
and the episodic use of PCPs, observed associations were stron-
ger for PCP use within 6 h of urine collection as compared with
use 24 h prior to collection. PCP use did not predict MiBP or the
other phthalate metabolite urinary concentrations, which is con-
sistent with infrequent use of these phthalates in PCPs (Dodson
et al. 2012).
To our knowledge only two large-scale studies have investi-
gated the association between PCP use and urinary phthalate
metabolites and parabens in men. Duty et al. (2005) explored
associations of ﬁve PCPs used within 48 h of a single spot urine
sample collection in 406 men recruited from the MGH
Andrology Laboratory (2000–2003); cologne and aftershave
were predictors of MEP urinary concentrations (Duty et al.
2005). More recently, using NHANES data, Ferguson et al.
(2017) reported that mouthwash was a more important source of
paraben exposure in men than in women. Our results were con-
sistent with the ﬁndings from these previous studies even though
both relied on only one spot urine sample per participant and had
limited information about the time of PCP use relevant to the
urine collection. Duty et al. (2005) assessed PCP use within 48 h
before urine collection, which is likely to be too long a time win-
dow which would contribute to attenuation of associations.
Ferguson et al. (2017) had no information on last time of use rela-
tive to urine sample collection. Instead, PCP use was recorded as
always, sometimes, or never, introducing exposure misclassiﬁca-
tion that is likely nondiﬀerential. Our study, with repeated urine
samples from the same man and more detailed information on
time of PCP use extends the literature by identifying speciﬁc pre-
dictors of phthalates and parabens exposure.
In our study, men’s self-reported information on PCP use was
predictive of select phthalate (mainly DEP) and paraben expo-
sures. Based on our results, the exposure assessment of phthalates
and parabens can be improved by asking only about the most
“important” PCPs used within 6 h before urine collection. We
showed that 10 PCPs contributed to at least 70% of the weighted
score and explained more than a 250% increase in the urinary
concentrations of MEP and the three parabens. Our recommenda-
tion for reﬁning the questionnaire includes focusing on the fol-
lowing 10 PCPs: cologne/perfume, deodorant, suntan/sunblock
lotion, hand/body lotion, aftershave, other hair care products,
mouthwash, conditioner/crème rinse, hairspray/hair gel, and liq-
uid soap/body wash. Shortening the questionnaire would likely
decrease missingness and improve participants’ response rate. In
addition, restricting the period of inquiry to the 6 h prior to urine
collection would provide a more precise estimate of exposure to
phthalates and parabens because the urinary concentrations of the
biomarkers are a better reﬂection of exposure in the last 6 h than
in the last 24 h. It is also likely that participants will better recall
their PCP use within a shorter time frame.
continued
and ≤0900 hours), late morning (>0900 hours and ≤1200 hours), or afternoon (>1200 hours)], current smoking (yes/no) and warm season (April–September)
(yes/no). Analysis adjusted for urine speciﬁc gravity (continuous), race (Caucasian or not), age (continuous), BMI (continuous), calendar year (continuous),
time of sample collection [early morning (>0500 and ≤0900 hours), late morning (>0900 hours and ≤1200 hours), or afternoon (>1200 hours)], current smok-
ing (yes/no), warm season (April–September) (yes/no), and the product use within 24 h (yes/no). Total products: the crude sum of PCP used within 24 h. The total
products’ bar graphs plotting % change associated with each additional type of PCP used, regardless of which PCP. Combined other hair care products included
mousse, hair bleach, relaxer, perm, and straightener. Analysis was based on 10 imputed data using the chained equations method. *p-value<0:05.
**p-value<0:01.
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Our study had several potential limitations. First, our single-
PCP approach may be susceptible to multiple testing statistical
issues. However, we also used a multi-PCP approach using WBS
regression to account for multiple testing and the resulting esti-
mated % changes were even larger, making it unlikely that any
false positives in the single-PCP analysis accounted for our
ﬁndings. Butylparaben had a low detection frequency, which
was consistent with ﬁndings from the NHANES (Calafat et al.
2010; CDC 2017; Ferguson et al. 2017) and a German study
(Moos et al. 2015). We addressed this in two ways. First, to ex-
plicitly model nondetectable concentrations, we used Tobit
regression, which accounts for missingness better than replac-
ing those concentrations with the LOD divided by the square
root of 2 and linear regression (Ferguson et al. 2017). Second,
we applied a sensitivity analysis using GEE (detected vs. non-
detected) as performed before (Dodge et al. 2015), and these
sensitivity analyses produced results comparable to the Tobit
regression.
Figure 3.Weights of personal care products (PCPs) that contribute 100% and at least 70% to the overall urinary concentrations of biomarkers associated with
PCPs use within 24 h and 6 h of sample collection: A) weights of personal care products (PCPs) that contribute 100% to the overall urinary concentrations asso-
ciated with PCPs use within 24 h and their overall weighted % change; B) weights of personal care products (PCPs) that contribute 100% to the overall urinary
concentrations associated with PCPs use within 6 h and their overall weighted % change; C) weights of personal care products (PCPs) that contribute at least
70% to the overall urinary concentrations associated with PCPs use within 24 h and their overall weighted % change; D) weights of personal care products
(PCPs) that contribute at least 70% to the overall urinary concentrations associated with PCPs use within 6 h and their overall weighted % change. Numbers
presented inside the stack bars represent the weights associated with PCP use. The weights of the 14 PCPs are summed to ∼ 100 due to approximation. The
percent presented above the stacked bars represent the % change associated with PCPs. The weights presented are NOT summed to the % change, instead
summed to 100% for the 14 PCPs and 70% or more for the PCPs presented above. The % changes are calculated by exponentiation of the weighted beta coeﬃ-
cient based on the PCPs used given the weights. Multiple imputation of the missing was based on concordance of product use within persons. For any given
PCP at any time point, the imputation model included PCP use at other time points, urine speciﬁc gravity (continuous), race (Caucasian or not), age (continu-
ous), BMI (continuous), calendar year (continuous), time of sample collection [early morning (>0500 and ≤0900 hours), late morning (>0900 hours and
≤1200 hours), or afternoon (>1200 hours)], current smoking (yes/no), and warm season (April–September) (yes/no). Analysis adjusted for urine speciﬁc grav-
ity (continuous), race (Caucasian or not), age (continuous), BMI (continuous), calendar year (continuous), time of sample collection [early morning (>0500
and ≤0900 hours), late morning (>0900 hours and ≤1200 hours), or afternoon (>1200 hours)], current smoking (yes/no), warm season (April–September) (yes/
no), and the product use within 24 h (yes/no). Combined other hair care products included mousse, hair bleach, relaxer, perm, and straightener. Analysis was
based on 10 imputed data using the chained equations method.
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We had no information about frequency of PCP use, amount
of product used, whether it was used with hot or cold water,
phthalates and parabens product content, or brand names of the
PCPs. Nevertheless, the lack of this information would have
likely introduced nondiﬀerential measurement error and thus atte-
nuated our results toward the null. In addition, knowing the brand
name may not remedy this potential limitation given that even
the same brand might change product formulations over time and
chemicals are not always listed on product labels. Because of
short half-lives and episodic use, urinary concentrations of the
biomarkers will depend on the frequency of voids between PCP
use and urine collection and we did not collect this information.
We only focused on exposures from PCP use, not accounting for
other exposure sources. However, this is less likely to aﬀect our
results for MEP and the parabens because the PCPs are consid-
ered a major source of exposure to these compounds (or their pre-
cursors) (Braun et al. 2014; Janjua et al. 2007, 2008; Just et al.
2010), whereas for other phthalates such as DEHP, food is a
major source of exposure (Serrano et al. 2014). In addition, it is
unlikely that other sources of exposure such as diet would meet
the confounder deﬁnition because they are unlikely to be associ-
ated with PCP use, hence not aﬀecting the study validity. Finally,
most men in our study were Caucasian, overweight or obese,
highly educated, and nonsmokers. Therefore, our results may be
generalized only to men with similar characteristics.
Our study had several strengths, including the use of repeated
collection of self-reported PCP use and urinary concentrations of
phthalate metabolites and parabens for a large number of men
over a 10-y period; these repeated urine samples likely increased
the precision of the measurements compared with a single sam-
ple. We included in the analysis 14 PCPs, the largest number of
PCPs investigated in men to date. We also included a large num-
ber of phthalate metabolites and 3 parabens. We assessed PCP
use within 24 and 6 h before urine collection, more relevant ex-
posure windows compared with PCP use within the last 48 h
(Duty et al. 2005; Just et al. 2010).
Another novel aspect of our study compared with previous
research was the use of a weighted PCP score to predict urinary
concentrations. The WBS analyses yielded diﬀerent weights for
each PCP depending on the association with each biomarker.
Using the single-PCP analyses for modeling, the crude sum of
PCPs likely attenuated the eﬀect due to nondiﬀerential misclassi-
ﬁcation by giving equal weights to each PCP in association with
each biomarker. In addition, the multi-PCP approach was able to
adjust for the other correlated PCPs and estimate the joint eﬀect
of multiple PCP use, rather than simply using the crude sum of
the PCPs or modeling each PCP separately. This approach has
been used in linear regression settings (Carrico 2013; Carrico
et al. 2015; Christensen et al. 2013; Gennings et al. 2010, 2013),
and we extended the basic weighted quantile strategy used in ear-
lier work to the repeated measures data and in Tobit regression
framework.
Conclusions
Among a large cohort of men, we identiﬁed PCP predictors of
urinary concentrations of MEP and three parabens. The results
will be useful in future exposure assessment studies on PCP use
as an important source of exposure to phthalates (mainly DEP)
and parabens. Collecting concise PCP use information can be
achieved by only asking speciﬁc questions about the use of the
most relevant PCPs within a narrow exposure window (6 h) to
potentially decrease missingness and improve recall decreasing
misclassiﬁcation while also optimizing research cost and time.
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